So that's our biologic approach right now.

What about getting to a total biologic knee replacement, not just the parts?

This is the field of biologic replacements, where we replace worn out parts with new, natural ones.

And so that's not going to be a solution that's going to get us global with biologic tissue.

We can strip that tissue very economically, and so this is how we can get biologic knee replacement to go global.

The health of the individual and of society proceed comprehensively out of an interaction of biologic basics, external factors of the environment (socio economic conditions, conditions of life, the political and cultural environment) and, of course, the quality of health care.

The US is pushing for longer copyright protection for published works, music, and films. It also wants technical changes that would effectively mean much longer patent terms for pharmaceuticals, make the approval process lengthier for generic drug makers, and extend protections for biologic medicines.

So what we're going to do is take an articular cartilage from a young, healthy pig, strip it of its antigens, load it with your stem cells, then put it back on to that arthritic surface in your knee, tack it on there, have you heal that surface and then create a new biologic surface for your knee.